Please support SENS Research on Amazon Smile this Christmas smile
Dont forget you can help SENS Research Foundation even during your Christmas shopping this year! Using Amazon Smile you can buy your gifts in the normal way but Amazon will donate 0.5% of the price of your eligible AmazonSmile purchases to us whenever you shop on AmazonSmile. bigsmile
#aging #sens
When does Westworld return for season 2? (HBO)
Westworld has been a wonderful show with intricate layers-upon-layers. It seems destined to be the next Game of Thrones for HBO and could reach the level of popularity that Lost enjoyed. J.J. Abrams definitely has another hit on his hands. But now that the first season has ended far too soon, when does the second season begin? Unfortunately, it will likely be farther away than you’re hoping.
First, the good news. Westworld has indeed been renewed for a second season. Season 2 will run for 10 episodes, just like Season 1, according to EW.
Continue reading “‘Westworld’ Season 2: When Does the Show Return?” »
Read this introductory list of contemporary machine learning algorithms of importance that every engineer should understand.
By James Le, New Story Charity.
Continue reading “The 10 Algorithms Machine Learning Engineers Need to Know” »
It is not often that a scientist walks the red carpet at a Silicon Valley party and has Morgan Freeman award them millions of dollars while Alicia Keys performs on stage and other A-listers rub shoulders with NASA astronauts.
But the guest list for the Breakthrough prize ceremony is intended to make it an occasion. At the fifth such event in California last night, a handful of the world’s top researchers left their labs behind for the limelight. Honoured for their work on black holes and string theory, DNA repair and rare diseases, and unfathomable modifications to Schrödinger’s equation, they went home to newly recharged bank accounts.
Founded by Yuri Milner, the billionaire tech investor, with Facebook’s Mark Zuckerberg and Google’s Sergey Brin, the Breakthrough prizes aim to right a perceived wrong: that scientists and engineers are not appreciated by society. With lucrative prizes and a lavish party dubbed “the Oscars of science”, Milner and his companions want to elevate scientists to rock star status.
Continue reading “Breakthrough prize awards $25m to researchers at ‘Oscars of science’” »
A brand new type of HIV vaccine will move onto phase II clinical trials in 2017, after phase I trials showed that it was safe to use in humans.
The potential new vaccine will be tested on 600 people in North America, to see how well it can prevent them from getting the virus.
Before we get too excited, the phase I trials were only set up to show that the vaccine was tolerated well by the human body — they didn’t demonstrate if it actually works as a preventative treatment.
Continue reading “A First-of-Its-Kind HIV Vaccine Will Move to Phase II Trials in 2017” »
A Bill Andrews speech. You can watch the whole thing but the meat of it starts at about the 14 minute mark.
[Ch.19] 세상에 없는 TV 이제 시작합니다.
Continue reading “[GLOBAL LEADERS FORUM 2016] Session 1 — Bill Andrews [ENG]” »
Scientists hoping to get a glimpse of molecules that control brain activity have devised a new probe that allows them to image these molecules without using any chemical or radioactive labels.
Currently the gold standard approach to imaging molecules in the brain is to tag them with radioactive probes. However, these probes offer low resolution and they can’t easily be used to watch dynamic events, says Alan Jasanoff, an MIT professor of biological engineering.
Jasanoff and his colleagues have developed new sensors consisting of proteins designed to detect a particular target, which causes them to dilate blood vessels in the immediate area. This produces a change in blood flow that can be imaged with magnetic resonance imaging (MRI) or other imaging techniques.
Continue reading “A radiation-free approach to imaging molecules in the brain” »
Great.
Research published in Acta Neuropathologica, identified alterations in a protein known as ATRX in human brain tumours; researchers might also be able to target microRNAs directly, altering their levels to make cancer cells less likely to form tumours.
A recent study suggests that two recently discovered genetic differences between brain cancer cells and normal tissue cells could offer clues to tumour behaviour and potential new targets for therapy.
Continue reading “Research sets new target for brain cancer therapy” »
